BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8694541)

  • 1. Tumor markers as targets for selective diagnostic and therapeutic procedures.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Ferroni P; Diodati A; Anselmi D; Cipriani C; Casciani CU; Greiner J; Schlom J
    Anticancer Res; 1996; 16(4B):2187-92. PubMed ID: 8694541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of B72.3 staining in "suspicious" fine needle aspiration biopsies of the breast.
    Pohoresky J; Yazdi HM
    Acta Cytol; 1991; 35(2):254-5. PubMed ID: 2028702
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers].
    Cazin JL; Gosselin P; Demaille A
    Pathol Biol (Paris); 1993 Nov; 41(9):881-6. PubMed ID: 8121720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies as applied to tumor-associated antigens: the CO17-1A antigen.
    Ross AH; Herlyn D; Steplewski Z; Koprowski H
    Immunol Ser; 1989; 43():107-22. PubMed ID: 2490493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies.
    Flynn MK; Johnston W; Bigner S
    Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated antigens and biomarkers in cancer and immune therapy.
    Malyankar UM
    Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in the use of monoclonal antibodies for imaging and therapy.
    Monson JR
    Curr Opin Gen Surg; 1993; ():334-9. PubMed ID: 7584004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of monoclonal antibodies to tumor diagnosis and therapy.
    Rosen ST; Winter JN; Epstein AL
    Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of monoclonal antibodies in the cytologic evaluation of tumors.
    Szpak C; McLendon RE; Simpson JF; Thor A; Johnston WW
    Clin Lab Med; 1990 Mar; 10(1):77-103. PubMed ID: 2184981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's new in cancer monitoring?
    Matzku S
    Pathol Res Pract; 1987 Oct; 182(5):699-703. PubMed ID: 3317325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor markers as target substances in the radioimmunologic detection of malignancies.
    von Kleist S
    Nuklearmedizin; 1986 Aug; 25(4):125-7. PubMed ID: 3532036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients.
    Roselli M; Guadagni F; Buonomo O; Lombardo A; Diodati A; Vittorini V; Belardi A; Cipriani C; Casciani CU
    In Vivo; 1993; 7(6B):615-21. PubMed ID: 8193282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry in the evaluation of melanocytic tumors.
    Ruiter DJ; Bröcker EB
    Semin Diagn Pathol; 1993 Feb; 10(1):76-91. PubMed ID: 8506418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemistry and histochemistry of new tumor-associated antigens and their relation to blood group substances].
    Vierbuchen M; Larena A; Hanisch FG; Uhlenbruck G
    Verh Dtsch Ges Inn Med; 1991; 97():420-49. PubMed ID: 1808924
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible applications of antibodies or their genes in cancer therapy.
    Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
    Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunodetection: technical problems and methods of improvement.
    Sergides IG; Austin RC; Winslet MC
    Eur J Surg Oncol; 1999 Oct; 25(5):529-39. PubMed ID: 10527603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies in oncology: applications in diagnosis, prognosis and prediction of response to therapy on tissue specimens].
    Penault-Llorca FM; Balaton AJ
    Bull Cancer; 2000 Nov; 87(11):794-803. PubMed ID: 11125288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.